Use of a high-frequency electrical stimulation device after cesarean delivery is associated with reduced opioid use, according to a study published online Oct. 20 in JAMA Network Open.
Oct 20, 2023
0
0
Cedars-Sinai Cancer investigators have identified two promising new treatment options for men with recurrent prostate cancer—both of which helped patients live longer without their disease progressing than the current standard ...
Oct 18, 2023
0
44
A study published today in The Annals of Thoracic Surgery demonstrates outstanding long-term survival following low-risk isolated surgical aortic valve replacement (SAVR).
Oct 17, 2023
0
12
Research led by the Feinberg School of Medicine, Northwestern University, Illinois, found that home-based walking exercise regimens outperformed supervised treadmill physical therapy in patients with lower extremity peripheral ...
Nearly one in three Americans wear a wearable device, like a smartwatch, to track their health and fitness.
Sep 26, 2023
0
0
The sensitivity of the brain to insulin may be modulated by menstrual cycle phase, a paper published in Nature Metabolism suggests. The findings are based on a randomized clinical trial involving 11 women.
Sep 24, 2023
0
68
In a new study published in JAMA and led by researchers at Brigham and Women's Hospital has found that patients prescribed amoxicillin-clavulanate had higher rates of gastrointestinal symptoms and yeast infections than those ...
Sep 19, 2023
0
36
Skipping genetic counseling before or after taking a remote screening of inherited risk for ovarian or breast cancer does not increase distress, anxiety or depression, according to a study published Sept. 14 in JAMA Oncology.
Sep 19, 2023
0
6
An innovative phase 2 clinical trial led by Dana-Farber Cancer Institute, in collaboration with 10 major brain tumor centers around the country and designed to find new potential treatments for glioblastoma, has reported ...
Sep 18, 2023
0
0
A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University found no symptomatic or clinical benefit to taking the antidepressant fluvoxamine at a dosage of 100 mg twice daily for ...
Sep 14, 2023
0
0
